InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-04 · accession 0001415889-24-026147 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-05 2024-11-04 UTHR EDGEMOND JAMES CFO AND Treas S - Sale+OE $374.02 -7,778 7,512 -51% -$2.91M
DM 2024-11-05 2024-11-04 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $118.99 +8,334 10.8K +341% +$991.6K
DM 2024-11-05 2024-11-04 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $0.00 -8,334 112.3K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-04 S D 565 $374.02 8,068 D — —
2 Common Common Stock 2024-11-04 M A 850 $117.76 8,633 D — —
3 Common Common Stock 2024-11-04 S D 546 $374.02 7,783 D — —
4 Common Common Stock 2024-11-04 M A 817 $120.26 8,329 D — —
5 Common Common Stock 2024-11-04 S D 3,400 $374.02 7,512 D — —
6 Common Common Stock 2024-11-04 M A 3,400 $117.76 10,912 D — —
7 Common Common Stock 2024-11-04 S D 3,267 $374.02 7,512 D — —
8 Common Common Stock 2024-11-04 M A 3,267 $120.26 10,779 D — —
9 Derivative Stock Options 2024-11-04 M D 3,267 $0.00 817 D $120.26 · 2017-03-15 to 2026-03-15 3,267 Common Stock
10 Derivative Stock Options 2024-11-04 M D 817 $0.00 0 D $120.26 · 2017-03-15 to 2026-03-15 817 Common Stock
11 Derivative Stock Options 2024-11-04 M D 850 $0.00 111,500 D $117.76 · 2021-03-15 to 2027-03-15 850 Common Stock
12 Derivative Stock Options 2024-11-04 M D 3,400 $0.00 112,350 D $117.76 · 2021-03-15 to 2027-03-15 3,400 Common Stock